Home > Insider Trading > Filing (0001021771-24-000091)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1505497	Biorestorative Therapies Inc.	BRTX	Services-Misc Health & Allied Services, Nec (8090)	301341024

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1527241	Francisco Silva	C/O Biorestorative Therapies, Inc. 40 Marcus Drive Melville NY 11747	Vp Of Research And Development	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-04-08	476	$1.13	147,927	No	4	P	Direct
Common Stock	Acquisiton	2024-04-08	1,232	$1.17	149,159	No	4	P	Direct
Common Stock	Acquisiton	2024-04-09	6,600	$1.25	155,759	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,136	Indirect	IRA

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$3,000.00	2024-10-23	9	9	Direct
Common Stock	Stock Option	$3,000.00	2025-09-04	6	6	Direct
Common Stock	Stock Option	$3,000.00	2026-06-10	15	15	Direct
Common Stock	Stock Option	$3,000.00	2027-07-12	20	20	Direct
Common Stock	Stock Option	$3,000.00	2028-10-29	25	25	Direct
Common Stock	Stock Option	$5.08	2031-03-18	293,479	293,479	Direct
Common Stock	Stock Option	$5.08	2031-11-04	42,059	42,059	Direct
Common Stock	Stock Option	$2.91	2033-02-17	106,762	106,762	Direct
Common Stock	Stock Option	$1.45	2034-02-13	394,737	394,737	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-10-23	9	9	Direct
2025-09-04	6	6	Direct
2026-06-10	15	15	Direct
2027-07-12	20	20	Direct
2028-10-29	25	25	Direct
2031-03-18	293,479	293,479	Direct
2031-11-04	42,059	42,059	Direct
2033-02-17	106,762	106,762	Direct
2034-02-13	394,737	394,737	Direct

Footnotes

The option is currently exercisable.
The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
The option vests and becomes exercisable to the extent of 197,369 shares on February 13, 2024 and 197,368 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.